NCT06924892

Brief Summary

The study team sought to scientifically investigate strategic subsets of depressed individuals or people prone to or at-risk of depression through music experiences of individual, group, and blended supported contexts. Meetings with the study multi-disciplinary team, included member of the Carnegie Hall Weill Music Institute and University affiliates, where the study team gathered quantitative and qualitative data in individual and group forums, measuring disease process and levels of participation. Through tabulation of participatory options with standardized depression and resilience measurements, the study team studied how live music could alter depressive symptoms over time and/ or change negative influencers of mood, shift quality of life, and lead toward possibly enhanced disease trajectory outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 5, 2023

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 24, 2025

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 30, 2025

Completed
5 days until next milestone

First Submitted

Initial submission to the registry

April 4, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 11, 2025

Completed
Last Updated

October 20, 2025

Status Verified

October 1, 2025

Enrollment Period

2 years

First QC Date

April 4, 2025

Last Update Submit

October 15, 2025

Conditions

Keywords

DepressionMusic AssessmentMusic TherapyAnxiety

Outcome Measures

Primary Outcomes (3)

  • Connor-Davidson Resilience Scale (CD-RISC)

    The Connor-Davidson Resilience Scale (CD-RISC) measures inherent resiliency. The 10-item instrument has high internal consistency. Each item consists of a 5-point Likert scale (scored from zero to four). Ranging from 0-40 with higher scores reflecting greater perceived resilience.

    end of study at 3 months

  • The Beck Depression Inventory Second Edition (BDI-II) score

    The Beck Depression Inventory Second Edition (BDI-II) is a multiple-choice self-report inventory that assesses severity of depression. The BDI-II contains 21 items on a 4-point scale from 0 (symptom absent) to 3 (severe symptoms). The minimum score is 0 and the maximum score is 63, with a higher score indicating more severe depressive symptoms.

    end of study at 3 months

  • Child Depression Inventory

    The total score range 0 to 54 which is converted to a T-Score, higher score indicates more symptoms.

    end of study at 3 months

Study Arms (2)

Music Therapy

EXPERIMENTAL

Music therapy session for 3 months once a week

Behavioral: Music therapy

Wellness Concerts

OTHER

Participants attended wellness concerts.

Other: Wellness Concerts

Interventions

Music therapyBEHAVIORAL

Independent music therapy 45-minute sessions provided weekly for 3 months

Also known as: Music
Music Therapy

Wellness Concerts provided at partner sites (Carnegie Hall Weill Music Institute, Cooper Union College, Third Street Music Settlement).

Wellness Concerts

Eligibility Criteria

Age8 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Participants between the ages of 8-70 years with a clinical diagnosis of Major Depressive Disorder (MOD) who met the DSM-5 (2013) criteria for a Major Depressive Episode, and/or who identify themselves, or are identified by family, or referring clinicians as depressed, or are prone to depression
  • Depressive episodes and/or showing symptoms of mild to moderate depression intensity
  • Self-reported satisfactory bilateral hearing
  • English or Spanish language fluency sufficient to complete the interviews and questionnaires

You may not qualify if:

  • Axis I diagnosis, aside from MOD, considered the primary diagnosis
  • Bipolar Disorder Type I or II,
  • Axis II diagnosis such as antisocial or borderline.
  • Arrhythmia,
  • Pacemaker
  • Prolapsed vertebral disc, and
  • Recent back or neck injuries.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Sinai Union Square

New York, New York, 10003, United States

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Interventions

Music Therapy

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsRehabilitationAftercareContinuity of Patient CarePatient CarePsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Joanne Loewy

    Icahn School of Medicine at Mount Sinai

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Participants were provided options for various music study inclusions
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Music therapy or no intervention provided for all consented participants
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor/Director

Study Record Dates

First Submitted

April 4, 2025

First Posted

April 11, 2025

Study Start

April 5, 2023

Primary Completion

March 24, 2025

Study Completion

March 30, 2025

Last Updated

October 20, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in this article, after deidentification.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Beginning 3 months and ending 5 years following article publication.
Access Criteria
Investigators whose proposed use of the data has been approved by an independent review committee ('learned intermediary') identified for this purpose. To achieve aims in the approved proposal. Proposals should be directed to Joanne.Loewy@mountsinai.org. To gain access, data requestors will need to sign a data access agreement. Data are available for 5 years at a third-party website (Link included in the URL field below)
More information

Locations